Jobs filters
RESEARCH ASSOCIATE I - HEMATOPOIETIC TISSUE BIOREPOSITORY - 10025001
Orange, CAPHYSICIAN - MEDICAL ONCOLOGY - ANTELOPE VALLEY, CA - 10024260
Lancaster, CAACUPUNCTURIST - CHERNG FAMILY CENTER FOR INTEGRATIVE ONCOLOGY - 10025056
Duarte, CAGI PATHOLOGIST - 10025200
Duarte, CASTAFF SCIENTIST - STEM CELLS AND GENOME EDITING - 10024688
Duarte, CASTAFF SCIENTIST - CAR T RESEARCH - 10024476
Duarte, CAPROTOCOL DEVELOPMENT SPECIALIST - 10024796
Irwindale, CAASSOCIATE PROFESSOR - 10024822
Duarte, CASENIOR RESEARCH ASSOCIATE - LAB MANAGER - 10024929
Duarte, CACANCER CENTER ADMINISTRATOR - 10024613
Duarte, CAPHYSICIAN - BREAST MEDICAL ONCOLOGY - 10024229
Duarte, CARESEARCH ASSOCIATE II - INTEGRATIVE TRANSLATIONAL SCIENCES - 10024455
Duarte, CA
RESEARCH ASSOCIATE II - INTEGRATIVE TRANSLATIONAL SCIENCES - 10024455
Duarte, CACity of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases.
Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a wholly owned subsidiary, was launched in 2019 and is dedicated to serving employers and their health care partners by providing access to City of Hope’s exceptional cancer expertise.
A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.
Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope, where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a common mission: Contribute to innovative approaches in predicting, preventing, and curing diseases, shaping the future of medicine through cutting-edge research.
The Department of Integrative Translational Sciences is seeking a Research Associate II to join Dr. David Craig’s laboratory. Our team is dedicated to translating our findings into novel therapeutic strategies to improve patient outcomes, by focusing on focuses on cutting-edge research aimed at understanding molecular mechanisms in health and disease. For more information on Dr. Craig’s research, please visit here.
As a successful candidate, you will:
- Conduct a range of molecular biology experiments, focusing on techniques such as cell culture, biochemical assays, and DNA damage detection.
- Execute and analyze single-cell, spatial, and NGS workflows, emphasizing library construction and sequencing from cells and primary tissues.
- Develop and optimize cutting-edge single cell-based genomics technologies.
- Participate in long-read sequencing and associated data analysis.
- Perform histological preparations, with a focus on formalin-fixed paraffin-embedded (FFPE) tissues.
Your qualifications should include:
· Bachelor's degree in Molecular Biology, Genetics, Biochemistry, or in a related field, along with 2 years of experience. Alternatively, a Master's degree with 1 year of experience is acceptable.
· Hands-on experience in standard molecular biology techniques, with emphasis on cellular biology.
· Experience with emerging genomic methods, including single-cell and spatial transcriptomics, and long-read sequencing methodologies.
· Strong skills in histology and tissue preparation, especially with FFPE samples.
· Excellent interpersonal communication skills with a high emphasis on collaboration.
City of Hope is an equal opportunity employer. To learn more about our commitment to diversity, equity, and inclusion, please click here.